| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |